Chemed (CHE) Insider Trading & Ownership $544.75 -5.35 (-0.97%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$545.90 +1.15 (+0.21%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Chemed (NYSE:CHE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.32%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$75,327.50Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$20.26 M Get CHE Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CHE Insider Buying and Selling by Quarter Chemed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/30/2024Brian C JudkinsVPBuy145$519.50$75,327.50 11/27/2024Spencer S LeeEVPSell732$575.62$421,353.84 11/25/2024Kevin J McnamaraCEOSell2,000$572.77$1,145,540.00 9/26/2024George J Walsh IIIDirectorSell400$597.47$238,988.00 9/26/2024Kevin J McnamaraCEOSell2,000$598.81$1,197,620.00 9/9/2024Nicholas Michael WestfallEVPSell1,713$569.35$975,296.55 8/21/2024George J Walsh IIIDirectorSell200$577.95$115,590.00 8/16/2024Andrea R LindellDirectorSell831$571.51$474,924.81 8/5/2024Kevin J McnamaraCEOSell2,000$569.63$1,139,260.00 7/30/2024Nicholas Michael WestfallEVPSell2,000$561.58$1,123,160.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/12/2024Patrick P GraceDirectorSell284$540.98$153,638.32 6/6/2024Kevin J McnamaraCEOSell1,500$544.17$816,255.00 5/16/2024Kevin J McnamaraCEOSell4,000$567.54$2,270,160.00 3/28/2024Spencer S LeeEVPSell2,000$641.65$1,283,300.00 3/21/2024Michael D WitzemanCFOSell2,650$643.14$1,704,321.00 3/20/2024Brian C JudkinsVPSell11,158$645.00$7,196,910.00 (Data available from 1/1/2013 forward) CHE Insider Trading Activity - Frequently Asked Questions Who is on Chemed's Insider Roster? The list of insiders at Chemed includes Andrea R Lindell, Brian C Judkins, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, and Spencer S Lee. Learn more on insiders at CHE. What percentage of Chemed stock is owned by insiders? 3.32% of Chemed stock is owned by insiders. Learn more on CHE's insider holdings. Which Chemed insiders have been buying company stock? The following insider purchased CHE shares in the last 24 months: Brian C Judkins ($75,327.50). How much insider buying is happening at Chemed? Insiders have purchased a total of 145 CHE shares in the last 24 months for a total of $75,327.50 bought. Which Chemed insiders have been selling company stock? The following insiders have sold CHE shares in the last 24 months: Andrea R Lindell ($474,924.81), Brian C Judkins ($7,196,910.00), David Patrick Williams ($10,736,274.48), George J Walsh III ($354,578.00), Kevin J Mcnamara ($17,087,920.00), Michael D Witzeman ($1,704,321.00), Nicholas Michael Westfall ($2,817,108.75), Patrick P Grace ($313,644.88), and Spencer S Lee ($2,994,929.29). How much insider selling is happening at Chemed? Insiders have sold a total of 75,623 Chemed shares in the last 24 months for a total of $43,680,611.21 sold. Chemed Key ExecutivesMr. Kevin J. McNamara (Age 70)CEO, President & Director Compensation: $5.84M2 recent tradesMr. Michael D. Witzeman CPA (Age 53)MBA, VP, Controller, Principal Accounting Officer & CFO Compensation: $1.15MMr. Spencer S. Lee (Age 68)Executive Vice President Compensation: $1.65M1 recent tradesMr. Thomas C. Hutton (Age 73)VP & Director Mr. Nicholas Michael Westfall (Age 45)Executive Vice President Compensation: $2.5M1 recent tradesMs. Lisa A. ReinhardVP, Chief Administrative Officer & SecretarySherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 43)VP, Secretary & Chief Legal Officer 1 recent trades More Insider Trading Tools from MarketBeat Related Companies Laboratory Co. of America Insider Selling Quest Diagnostics Insider Selling DaVita Insider Selling CorVel Insider Selling Amedisys Insider Selling Pediatrix Medical Group Insider Selling AMN Healthcare Services Insider Selling Cross Country Healthcare Insider Selling Option Care Health Insider Selling BrightSpring Health Services Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NYSE:CHE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
